Sanj K Patel insider trades: Kiniksa Pharmaceuticals International (KNSA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sanj reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | KNSA | ↓ Sell | 151,300 | $94.71 | $14.3M | Held by The Anglia 2013 Revocable Trust | Nov 6, 2026 (2d) |
| Nov 3, 2026 | KNSA | ↓ Sell | 402,494 | $92.92 | $37.4M | Held by The Anglia 2013 Revocable Trust | Nov 3, 2026 (0d) |
| Apr 30, 2026 | KNSA | ↓ Sell | 508,339 | $51.96 | $26.4M | Direct | Apr 30, 2026 (0d) |
| Apr 6, 2026 | KNSA | ↓ Sell | 7,278 | $50.01 | $364K | Direct | Apr 8, 2026 (2d) |
| Oct 22, 2025 | KNSA | ↓ Sell | 257,969 | $38.86 | $10.0M | Direct | Oct 22, 2025 (0d) |
| May 28, 2025 | KNSA | ↓ Sell | 86,270 | $27.24 | $2.3M | Direct | May 28, 2025 (0d) |
| May 20, 2025 | KNSA | ↓ Sell | 2,349 | $27.02 | $63K | Direct | May 22, 2025 (2d) |
| May 13, 2025 | KNSA | ↓ Sell | 2,872 | $27.03 | $78K | Direct | May 15, 2025 (2d) |
| May 9, 2025 | KNSA | ↓ Sell | 8,095 | $27.04 | $219K | Direct | May 9, 2025 (0d) |
| Nov 6, 2024 | KNSA | ↓ Sell | 89,561 | $23.00 | $2.1M | Direct | Nov 8, 2024 (2d) |
| Jul 23, 2024 | KNSA | ↓ Sell | 136,124 | $25.65 | $3.5M | Direct | Jul 25, 2024 (2d) |
| Mar 7, 2024 | KNSA | ↓ Sell | 65,012 | $21.02 | $1.4M | Held by The Anglia 2013 Revocable Trust, | Mar 11, 2024 (4d) |
| Mar 6, 2024 | KNSA | ↓ Sell | 18,324 | $21.34 | $391K | Held by The Anglia 2013 Revocable Trust, | Mar 6, 2024 (0d) |
| Feb 10, 2021 | KNSA | ↓ Sell | 29,234 | $23.07 | $674K | Held by the Anglia 2013 Revocable Trust, | Feb 10, 2021 (0d) |
| Feb 10, 2021 | KNSA | ↓ Sell | 26,925 | $23.03 | $620K | Direct | Feb 10, 2021 (0d) |
| Oct 12, 2020 | KNSA | ↓ Sell | 151,572 | $21.02 | $3.2M | Direct | Oct 14, 2020 (2d) |
| Oct 12, 2020 | KNSA | ↓ Sell | 100,000 | $21.02 | $2.1M | Held by the Anglia 2013 Revocable Trust, | Oct 14, 2020 (2d) |
| Mar 6, 2020 | KNSA | ↓ Sell | 33,115 | $20.00 | $662K | Held by the Anglia 2013 Revocable Trust, | Mar 10, 2020 (4d) |
| Dec 17, 2014 | GEVA | ↓ Sell | 50,000 | $88.85 | $4.4M | Direct | Dec 19, 2014 (2d) |
| Jan 29, 2014 | GEVA | ↓ Sell | 102,300 | $88.12 | $9.0M | Direct | Jan 30, 2014 (1d) |
| Jul 29, 2013 | GEVA | ↓ Sell | 100,000 | $48.02 | $4.8M | Direct | Jul 29, 2013 (0d) |
| Jun 12, 2013 | GEVA | ↓ Sell | 70,000 | $40.65 | $2.8M | Direct | Jun 13, 2013 (1d) |
| Apr 8, 2013 | GEVA | ↓ Sell | 31,605 | $49.68 | $1.6M | Direct | Apr 9, 2013 (1d) |
| Apr 4, 2013 | GEVA | ↓ Sell | 38,395 | $50.91 | $2.0M | Direct | Apr 5, 2013 (1d) |
| Feb 21, 2013 | GEVA | ↓ Sell | 70,000 | $49.19 | $3.4M | Direct | Feb 22, 2013 (1d) |
| Dec 17, 2012 | GEVA | ↓ Sell | 60,000 | $46.21 | $2.8M | Direct | Dec 17, 2012 (0d) |
| Dec 5, 2012 | GEVA | ↓ Sell | 35,000 | $48.92 | $1.7M | Direct | Dec 6, 2012 (1d) |
| Dec 3, 2012 | GEVA | ↓ Sell | 35,000 | $49.34 | $1.7M | Direct | Dec 4, 2012 (1d) |
| Sep 4, 2012 | GEVA | ↓ Sell | 70,000 | $49.47 | $3.5M | Direct | Sep 5, 2012 (1d) |
| Jun 4, 2012 | GEVA | ↓ Sell | 50,000 | $35.33 | $1.8M | Direct | Jun 5, 2012 (1d) |
| Mar 23, 2012 | GEVA | ↓ Sell | 50,000 | $33.53 | $1.7M | Direct | Mar 27, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KNSA insiders
Open-market trades in the last 12 months
About Sanj K Patel's insider trades
Sanj K Patel is Chairman & CEO at Kiniksa Pharmaceuticals International (KNSA). Since Mar 23, 2012, Sanj has reported no open-market purchases and 31 sales worth $147.0M on SEC Form 4. In the last 12 months: 4 sales ($78.5M).
Their filings also include option exercises (42 filings), grants and awards (31 filings), shares withheld for taxes (17 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KNSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.